| scholarly article | Q13442814 |
| P50 | author | Titia Lely | Q59163863 |
| Wilfred J Poppinga | Q39034448 | ||
| P2093 | author name string | Harry van Goor | |
| Ron Korstanje | |||
| Gerjan J Navis | |||
| Ute Schulze | |||
| Anthony J Turner | |||
| Nicola E Clarke | |||
| Inge Hamming | |||
| Jelena Kamilic | |||
| P2860 | cites work | Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats | Q44607639 |
| Individual differences in renal ACE activity in healthy rats predict susceptibility to adriamycin-induced renal damage. | Q45168718 | ||
| Differential ACE expression among tissues in allele-specific Wistar rat lines | Q46102744 | ||
| Transforming growth factor-beta 1 production is correlated with genetically determined ACE expression in congenic rats: a possible link between ACE genotype and diabetic nephropathy | Q47871917 | ||
| Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension | Q48524870 | ||
| Angiotensin-(1-7) and its effects in the kidney. | Q53385480 | ||
| Heme-oxygenase upregulation ameliorates angiotensin II-induced tubulointerstitial injury and salt-sensitive hypertension. | Q53582990 | ||
| ACE and ACE2 activity in diabetic mice. | Q54594958 | ||
| Angiotensin-converting enzyme polymorphism gene and evolution of nephropathy to end-stage renal disease. | Q54726519 | ||
| The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk | Q57085852 | ||
| Angiotensin-converting enzyme and angiotensin II receptor subtype 2 genotypes in type 1 diabetes and severe hypoglycaemia requiring emergency treatment: a case cohort study | Q57243037 | ||
| Angiotensin I-converting enzyme gene polymorphism influences chronic hypertensive response in the rat Goldblatt model | Q57244752 | ||
| Polymorphism of the angiotensin-converting enzyme (ACE) and angiotesinogen (AGT) genes and their associations with blood pressure and carotid artery intima media thickness among healthy Finnish young adults—the Cardiovascular Risk in Young Finns St | Q57417583 | ||
| Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism | Q72034083 | ||
| Strain differences in angiotensin-converting enzyme and angiotensin II type I receptor expression. Possible implications for experimental chronic renal transplant failure | Q78029521 | ||
| Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II | Q81079424 | ||
| A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 | ||
| Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase | Q28115041 | ||
| Angiotensin-converting enzyme 2 is an essential regulator of heart function | Q28205840 | ||
| Angiotensin-converting enzyme is a modifier of hypertensive end organ damage | Q28505768 | ||
| Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3 | Q28569602 | ||
| Genetic linkage of the ACE gene to plasma angiotensin-converting enzyme activity but not to blood pressure. A quantitative trait locus confers identical complex phenotypes in human and rat hypertension | Q28646023 | ||
| The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data | Q30664916 | ||
| Angiotensin-(1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin II within the cell nucleus | Q33652507 | ||
| Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis | Q33727783 | ||
| Asymmetric dimethylarginine in angiotensin II-induced hypertension | Q33728163 | ||
| An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
| Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease | Q34440225 | ||
| Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy. | Q34656882 | ||
| Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies | Q36063285 | ||
| The emerging role of ACE2 in physiology and disease | Q36804138 | ||
| Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension | Q36844520 | ||
| Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage? | Q37065754 | ||
| Hypertensive nephrosclerosis | Q37137413 | ||
| Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R. | Q37164522 | ||
| Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis | Q37492223 | ||
| Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. | Q40510688 | ||
| Influence of sex and diet on quantitative trait loci for HDL cholesterol levels in an SM/J by NZB/BlNJ intercross population | Q40528335 | ||
| Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. | Q40844226 | ||
| Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats. | Q41713891 | ||
| Human recombinant ACE2 reduces the progression of diabetic nephropathy | Q41786103 | ||
| Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease | Q43112990 | ||
| Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice | Q43148851 | ||
| Angiotensin converting enzyme DD genotype not associated with increased risk of coronary artery disease in the Iranian population. | Q43192483 | ||
| Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake | Q43931492 | ||
| Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression | Q44152987 | ||
| Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats | Q44181063 | ||
| Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. | Q44353743 | ||
| Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats | Q44477942 | ||
| The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus | Q44510037 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 420-429 | |
| P577 | publication date | 2011-07-25 | |
| P1433 | published in | Journal of the Renin-Angiotensin-Aldosterone System | Q6296180 |
| P1476 | title | Rat Ace allele variation determines susceptibility to AngII-induced renal damage | |
| P478 | volume | 12 |
Search more.